HYDROMORPHONE HYDROCHLORIDE
NDC 43602-004, hydromorphone hydrochloride, tablet, from Ascent Pharmaceuticals Inc.
- Product NDC
- 43602-004
- Status
- Listed
- Labeler
- Ascent Pharmaceuticals Inc
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210506
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/43602-004 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HYDROMORPHONE HYDROCHLORIDE8 mg/1
Pharmacologic classes
Full Opioid Agonists [MoA]; Opioid Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43602-004-05 | 43602000405 | 500 TABLET in 1 BOTTLE (43602-004-05) |
| 43602-004-30 | 43602000430 | 30 TABLET in 1 BOTTLE (43602-004-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4de15afe-d676-4faa-a34d-9b9cb20dbf54
Use it
Look up 43602-004 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43602-004 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43602-004. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.